Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Capital Employed: 2021-2024

Historic Return on Capital Employed for Oncology Institute (TOI) over the last 4 years, with FY2024 value amounting to 0.43%.

  • Oncology Institute's Return on Capital Employed rose 200.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.43% for FY2024, which is 500.0% down from last year.
  • Latest data reveals that Oncology Institute reported Return on Capital Employed of 0.43% as of FY2024, which was down 500.0% from 0.38% recorded in FY2023.
  • Over the past 5 years, Oncology Institute's Return on Capital Employed peaked at 0.38% during FY2023, and registered a low of 0.44% during FY2021.
  • Over the past 4 years, Oncology Institute's median Return on Capital Employed value was 0.42% (recorded in 2022), while the average stood at 0.41%.
  • Per our database at Business Quant, Oncology Institute's Return on Capital Employed skyrocketed by 300bps in 2022 and then plummeted by -500bps in 2024.
  • Annual analysis of 4 years shows Oncology Institute's Return on Capital Employed stood at 0.44% in 2021, then rose by 8bps to 0.4% in 2022, then rose by 5bps to 0.38% in 2023, then decreased by -13bps to 0.43% in 2024.
  • Its last three reported values are 0.43% in FY2024, 0.38% for FY2023, and 0.4% during FY2022.